Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11026 results:
[ Συντάκτης(Desc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Z
Zarogoulidis, P., Huang H., Yang M., Zhou J., Jiao Y., Wang Q., et al. (2020).  Pleurodesis and Immunotherapy in NSCLC; Medical Thoracoscopy or VATS?. J Cancer. 11(6), 1606-1613.
Zarogoulidis, K., Mylonaki E., Kakavelas P., Zarogoulidis P., Tsiouda T., Rapti E., et al. (2009).  Topotecan-carboplatin-etoposide combination as 1st line treatment in patients with small cell lung cancer.. Lung Cancer. 66(2), 226-30.
Zarogoulidis, P., Tsakiridis K., & Zarogoulidis K. (2013).  Lung cancer: an update on current and future diagnostic and treatment techniques.. J Thorac Dis. 5 Suppl 4, S341.
Zarogoulidis, P., Tryfon S., Sapalidis K., Tsakiridis K., Baka S., Huang H., et al. (2020).  Bronchial HPV; the good the bad and the unknown.. Respir Med Case Rep. 30, 101053.
Zarogoulidis, P., Darwiche K., Yarmus L., Spyratos D., Secen N., Hohenforst-Schmidt W., et al. (2014).  Defense mechanisms of the respiratory system and aerosol production systems.. Med Chem. 10(2), 123-36.
Zarogoulidis, P., Hohenforst-Schmidt W., Huang H., Sahpatzidou D., Freitag L., Sakkas L., et al. (2014).  A gene therapy induced emphysema model and the protective role of stem cells.. Diagn Pathol. 9, 195.
Zarogoulidis, P., Huang H., Bai C., Kosmidis C., Porpodis K., Kallianos A., et al. (2018).  A new mode of ventilation for interventional pulmonology. A case with EBUS-TBNA and debulking.. Respir Med Case Rep. 23, 38-42.
Zarogoulidis, P., Lampaki S., Yarmus L., Kioumis I., Pitsiou G., Katsikogiannis N., et al. (2014).  Interleukin-7 and interleukin-15 for cancer.. J Cancer. 5(9), 765-73.
Zarogoulidis, P., Darwiche K., Hohenforst-Schmidt W., Huang H., Li Q., Freitag L., et al. (2013).  Inhaled gene therapy in lung cancer: proof-of-concept for nano-oncology and nanobiotechnology in the management of lung cancer.. Future Oncol. 9(8), 1171-94.
Zarogoulidis, P., Athanasiou E., Tsiouda T., Hatzibougias D., Huang H., Bai C., et al. (2017).  Immunotherapy "Shock" a case series of PD-L1 100% and pembrolizumab first-line treatment.. Respir Med Case Rep. 22, 197-202.
Zarogoulidis, P., Sapalidis K., Fyntanidou V., Kosmidis C., Amaniti A., Koulouris C., et al. (2019).  Evaluating the use of elastography in endobronchial ultrasound technique as a diagnostic approach for mesothorax lymphadenopathy. Expert Review of Respiratory Medicine. 1375(121), 1153 - 1159.
Zarogoulidis, P., Cheva A., Zarampouka K., Huang H., Li C., Huang Y., et al. (2013).  Tocopherols and tocotrienols as anticancer treatment for lung cancer: future nutrition.. J Thorac Dis. 5(3), 349-52.
Zarogoulidis, P., Lampaki S., J Turner F., Huang H., Kakolyris S., Syrigos K., et al. (2014).  mTOR pathway: A current, up-to-date mini-review (Review).. Oncol Lett. 8(6), 2367-2370.
Zarogoulidis, P., Yarmus L., Darwiche K., Walter R., Huang H., Li Z., et al. (2013).  Interleukin-6 cytokine: a multifunctional glycoprotein for cancer.. Immunome Res. 9(62), 16535.
Zarogoulidis, P., Glaros D., Kioumis I., Terzi E., Porpodis K., Tsiotsios A., et al. (2012).  Clinical differences between influenza A (H1N1) virus and respiratory infection between the two waves in 2009 and 2010.. Int J Gen Med. 5, 675-82.
Zarogoulidis, P., Kontakiotis T., Tsakiridis K., Karanikas M., Simoglou C., Porpodis K., et al. (2012).  Difficult airway and difficult intubation in postintubation tracheal stenosis: a case report and literature review.. Ther Clin Risk Manag. 8, 279-86.
Zarogoulidis, K., Porpodis K., Domvri K., Eleftheriadou E., Ioannidou D., & Zarogoulidis P. (2016).  Diagnosing and treating pancoast tumors.. Expert Rev Respir Med. 10(12), 1255-1258.
Zarogoulidis, P., Kioumis I., Pitsiou G., Porpodis K., Lampaki S., Papaiwannou A., et al. (2014).  Pneumothorax: from definition to diagnosis and treatment.. J Thorac Dis. 6(Suppl 4), S372-6.
Zarogoulidis, P., Kontakiotis T., & Zarogoulidis K. (2012).  Inhaled gene therapy in lung cancer: "as for the future, our task is not to foresee it, but to enable it".. Ther Deliv. 3(8), 919-21.
Zarogoulidis, P., Petridis D., Ritzoulis C., Darwiche K., Kioumis I., Porpodis K., et al. (2013).  Internal mouthpiece designs as a future perspective for enhanced aerosol deposition. Comparative results for aerosol chemotherapy and aerosol antibiotics.. Int J Pharm. 456(2), 325-31.
Zarogoulidis, P., Hohenforst-Schmidt W., Darwiche K., Krauss L., Sparopoulou D., Sakkas L., et al. (2013).  2-diethylaminoethyl-dextran methyl methacrylate copolymer nonviral vector: still a long way toward the safety of aerosol gene therapy.. Gene Ther. 20(10), 1022-8.
Zarogoulidis, P., Tsakiridis K., Karapantzou C., Lampaki S., Kioumis I., Pitsiou G., et al. (2015).  Use of proteins as biomarkers and their role in carcinogenesis.. J Cancer. 6(1), 9-18.
Zarogoulidis, P., Laskou S., Katsaounis A., Pavlidis E., Giannakidis D., Koulouris C., et al. (2018).  Esophagus lyomyoma diagnosed with convex endobronchial ultrasound (EBUS).. Respir Med Case Rep. 24, 95-97.
Zarogoulidis, P., Constantinidis T., Steiropoulos P., Papanas N., Zarogoulidis K., & Maltezos E. (2011).  Are there any differences in clinical and laboratory findings on admission between H1N1 positive and negative patients with flu-like symptoms?. BMC Res Notes. 4, 4.
Zarogoulidis, K., Ziogas E., Boutsikou E., Zarogoulidis P., Darwiche K., Kontakiotis T., et al. (2013).  Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a phase II, randomized study.. Drug Des Devel Ther. 7, 611-7.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.